Back to MACQUARIE GROUP LTD MACQUARIE GROUP LTD

IOVAIOVA
24 quarters

Position history for MACQUARIE GROUP LTDMACQUARIE GROUP LTD's holdings in IOVANCE BIOTHERAPEUTICS INC

No. Macquarie Group exited its IOVA (Iovance Biotherapeutics) position in Q2 2025. Its Q1 2025 13F listed 4,791,235 shares worth $16M. Macquarie Group first reported IOVA in Q1 2019 and held it in 21 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$734,000

Total Shares Change

-77,210

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$1.72
0
2025-Q1
Increased
4.8M
+0.8%
$16M0.0%$3.33
28
2024-Q4
Increased
4.8M
+48.9%
$35.2M0.0%$7.40
40
2024-Q3
New
3.2M
-
$30M0.0%$9.39
40
2024-Q2
Exited
0
-100.0%
$00.0%$8.02
0
2024-Q1
New
122,053
-
$1.8M0.0%$14.82
36
2023-Q2
Exited
0
-100.0%
$00.0%$7.04
0
2023-Q1
Decreased
55,835
-1.2%
$341,0000.0%$6.11
0
2022-Q4
Decreased
56,509
-11.5%
$361,0000.0%$6.39
0
2022-Q3
Decreased
63,856
-3.8%
$634,0000.0%$9.58
0
2022-Q2
Increased
66,393
+2.7%
$733,0000.0%$11.04
25
2022-Q1
Increased
64,672
+12.2%
$1.1M0.0%$16.65
28
2021-Q4
Increased
57,653
+19.7%
$1.1M0.0%$19.09
30
2021-Q3
Decreased
48,181
-3.4%
$1.2M0.0%$24.66
0
2021-Q2
Increased
49,881
+14.6%
$1.3M0.0%$26.02
29
2021-Q1
Increased
43,538
+11.8%
$1.4M0.0%$31.66
28
2020-Q4
Decreased
38,929
-23.6%
$1.8M0.0%$46.40
0
2020-Q3
Decreased
50,975
-2.3%
$1.7M0.0%$32.92
0
2020-Q2
Increased
52,164
+15.0%
$1.4M0.0%$27.45
29
2020-Q1
Decreased
45,355
-26.2%
$1.4M0.0%$29.94
0
2019-Q4
Decreased
61,492
-3.4%
$1.7M0.0%$27.68
0
2019-Q3
Increased
63,624
+0.1%
$1.2M0.0%$18.20
25
2019-Q2
Decreased
63,590
-17.6%
$1.6M0.0%$24.52
0
2019-Q1
New
77,210
-
$734,0000.0%$9.51
34

Other major holders of IOVA: ARK Investment Management LLC, FRANKLIN TEMPLETON INC, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used